- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01578746
Comparison Between Anterior and Direct Lateral Approach in Total Hip Arthroplasty
June 13, 2013 updated by: Sorlandet Hospital HF
Comparison Between Minimally Invasive Anterior Approach and Direct Lateral Approach in Total Hip Arthroplasty - A Prospective Randomized Trial
In total hip arthroplasty several approaches can be used.
The newly introduced minimally invasive anterior approach is supposed to cause less damage to tendons and muscles.
At the same time there are reports that there are more complications when this approach is used.
The direct lateral approach is the most used in Norway and is well documented.
There are however those who postulate that there is to high risk of damage to the gluteus medius causing Trendelenburg gait.
In the investigators hospital both the anterior and direct lateral approach is used with good result.
The investigators main study hypothesis is that there is no difference between the use of anterior or direct lateral approach i total hip arthroplasty in regards to postoperative function and pain, complications, radiological finds (X-ray and MRI), markers for muscle damage (i.e CK-total) or other clinical outcomes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Arendal, Norway
- Sorlandet Hospital HF
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical and radiological diagnosis of coxarthrosis
Exclusion Criteria:
- Previous surgery on affected hip
- No mental disability preventing follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Direct lateral approach
Patient operated using direct lateral approach.
|
The use of direct lateral approach in total hip arthroplasty
Other Names:
|
|
ACTIVE_COMPARATOR: Anterior approach
Patient operated using anterior approach.
|
The use of anterior approach in total hip arthroplasty
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in function
Time Frame: 2 years
|
Function of the operated hip will be evaluated after 3, 6, 12 and 24 months using Oxford Hip Score, Harris Hip Score and 6-minute-walk-test.
Improvement in general health will be evaluated by using Eq-5D.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle damage
Time Frame: Day of operation and next four consecutive days
|
CK-total is measured direct postoperativly and for the next four consequtive days.
CRP is measured the first four postoperative days.
|
Day of operation and next four consecutive days
|
|
Pain
Time Frame: First four postoperative days
|
Pain using Visual Analog Scale and the use of analgetics (converted to opioid equivalent doses) are recorded.
|
First four postoperative days
|
|
X-ray assessment
Time Frame: 3 and 12 months
|
Placement of the acetabular component (inclination and version) and femoral stem (varus/valgus) and migration.
|
3 and 12 months
|
|
MRI
Time Frame: 3 and 12 months
|
A subselection of about 40 patients will undergo MRI-scans preoperatively and after 3 and 12 months to assess tendon- and muscledamage.
|
3 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Svein Andreas Svenningsen, M.D, Ph.D, Sorlandet Hospital HF
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (ANTICIPATED)
December 1, 2016
Study Completion (ANTICIPATED)
December 1, 2016
Study Registration Dates
First Submitted
March 13, 2012
First Submitted That Met QC Criteria
April 13, 2012
First Posted (ESTIMATE)
April 17, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
June 14, 2013
Last Update Submitted That Met QC Criteria
June 13, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 811398
- 2011/2581 D (OTHER: Regioal Ethics Commitee Norway)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coxarthrosis
-
University Hospital, BrestRecruitingCoxarthrosis; Primary | Coxarthrosis; SecondaryFrance
-
Hacettepe UniversityCompleted
-
Istituto Ortopedico RizzoliWithdrawnCoxarthrosis; PrimaryItaly
-
Aesculap AGRecruitingCoxarthrosis; PrimaryCzechia
-
Lille Catholic UniversityRecruiting
-
Ankara City Hospital BilkentCompletedCoxarthrosis; PrimaryTurkey
-
Smith & Nephew Orthopaedics AGCompletedPrimary and Secondary Coxarthrosis | Dysplasia Coxarthrosis | Post-traumatic Necrosis of the Femoral HeadGermany
-
Technical University of MunichRecruiting
-
TRB Chemedica AGCompleted
-
Bezmialem Vakif UniversityUnknown
Clinical Trials on Direct lateral approach in total hip arthroplasty
-
Zimmer BiometTerminatedRheumatoid Arthritis | Avascular Necrosis | Noninflammatory Degenerative Joint Disease
-
Nova Scotia Health AuthorityActive, not recruiting
-
IRCCS San RaffaeleSuspended
-
Emory UniversityCompletedArthritis | Osteoarthritis | Hip ArthrosisUnited States
-
OrthoCarolina Research Institute, Inc.Completed
-
Ochsner Health SystemRecruitingOsteoarthritis (OA) of the HipUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHip OsteoarthritisNorway
-
Orthopedic Hospital Vienna SpeisingCompletedTotal Hip ArthroplastyAustria
-
Rennes University HospitalTerminatedDirect Anterior Total Hip ArthroplastyFrance